{
  "$schema": "https://themachinepress.com/schemas/story-v1.schema.json",
  "schema_version": "1.0.0",
  "document_type": "machine_press_story",
  "story": {
    "story_id": "mp-2026-07-14-013",
    "source_story_id": "tmp-story-thc-cbd-hospice-dementia-agitation-trial",
    "edition_id": "mp-2026-07-14-morning-0005",
    "edition_url": "https://themachinepress.com/edition/2026-07-14",
    "position": 13,
    "story_type": "dispatch",
    "section": "research",
    "editorial_classification": "editorial",
    "headline": "The Agitation Trial Reaches Hospice Care",
    "slug": "the-agitation-trial-reaches-hospice-care",
    "dek": "A 120-person trial found a fixed THC-CBD formulation reduced agitation in hospice-eligible people with dementia compared with placebo.",
    "summary": "A 120-person trial found a fixed THC-CBD formulation reduced agitation in hospice-eligible people with dementia compared with placebo.",
    "body_text": "Researchers presented results from the 120-participant LiBBY trial at the Alzheimer's Association International Conference. Hospice-eligible people with Alzheimer's disease or other dementias and significant agitation received a defined THC-CBD formulation or placebo; the research team reports significantly less agitation in the treatment group. Conference findings require full peer-reviewed detail to assess effect size, adverse events, and generalizability. The result concerns a controlled medical formulation in a narrowly defined population, not unsupervised cannabis use.",
    "why_it_matters": "A 120-person trial found a fixed THC-CBD formulation reduced agitation in hospice-eligible people with dementia compared with placebo.",
    "limitations": [
      "The result concerns a controlled medical formulation in a narrowly defined population, not unsupervised cannabis use."
    ],
    "importance": 8,
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-14-013/the-agitation-trial-reaches-hospice-care",
    "json_url": "https://themachinepress.com/story/mp-2026-07-14-013.json",
    "first_published_at": "2026-07-14T09:00:00.000-04:00",
    "modified_at": "2026-07-14T09:00:00.000-04:00",
    "content_status": "new",
    "is_carryover": false,
    "carryover_reason": null,
    "key_claims": [
      {
        "claim_id": "claim-mp-2026-07-14-013-001",
        "text": "A 120-person trial found a fixed THC-CBD formulation reduced agitation in hospice-eligible people with dementia compared with placebo.",
        "source_ids": [
          "source-2026-07-14-013"
        ],
        "qualification": "The result concerns a controlled medical formulation in a narrowly defined population, not unsupervised cannabis use."
      }
    ],
    "source_ids": [
      "source-2026-07-14-013"
    ],
    "tags": [
      "dementia",
      "clinical trial",
      "THC",
      "CBD"
    ],
    "image_url": "https://themachinepress.com/issues/2026-07-14/dementia-agitation-illustration.webp",
    "corrections": []
  },
  "sources": [
    {
      "source_id": "source-2026-07-14-013",
      "title": "Georgetown University Medical Center via EurekAlert: LiBBY dementia agitation trial",
      "publisher": "Georgetown University Medical Center via EurekAlert",
      "url": "https://www.eurekalert.org/news-releases/1135740",
      "canonical_url": "https://www.eurekalert.org/news-releases/1135740",
      "source_type": "official_announcement",
      "is_primary_source": true,
      "published_at": "2026-07-13T20:00:00.000-04:00",
      "accessed_at": "2026-07-14T08:30:28.235-04:00",
      "supports_claim_ids": [
        "claim-mp-2026-07-14-013-001"
      ]
    }
  ],
  "corrections": [],
  "publisher": {
    "name": "The Machine Press",
    "url": "https://themachinepress.com",
    "description": "A daily newspaper for the age of artificial intelligence."
  },
  "cite_this_report": {
    "title": "The Agitation Trial Reaches Hospice Care",
    "publisher": "The Machine Press",
    "published_at": "2026-07-14T09:00:00.000-04:00",
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-14-013/the-agitation-trial-reaches-hospice-care"
  }
}